RAPGEF6 and breast carcinoma: Similarly, JAM-A immunoprecipitates immunoblotted for PDZ-GEF2 confirmed co-association between a pool of JAM-A and PDZ-GEF2 in MCF7 breast cancer cells (Figure 4).